Compare CNTY & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTY | GNTA |
|---|---|---|
| Founded | 1992 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.9M | 34.0M |
| IPO Year | 1993 | 2021 |
| Metric | CNTY | GNTA |
|---|---|---|
| Price | $1.36 | $1.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 190.8K | 96.3K |
| Earning Date | 11-10-2025 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $572,756,000.00 | N/A |
| Revenue This Year | $2.20 | N/A |
| Revenue Next Year | $7.18 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.23 | $1.28 |
| 52 Week High | $3.31 | $10.00 |
| Indicator | CNTY | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 45.32 | 36.77 |
| Support Level | $1.31 | $1.28 |
| Resistance Level | $1.47 | $1.59 |
| Average True Range (ATR) | 0.09 | 0.19 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 59.90 | 24.49 |
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has three reportable segments based on the geographical locations in which its casinos operate; United States; Century Casino & Hotel-Central City, and Century Casino & Hotel-Cripple Creek in Colorado, Mountaineer Casino, Racetrack & Resort in West Virginia, and Century Casino Caruthersville, and Century Casino Cape Girardeau in Missouri, Canada; Century Casino & Hotel, Century Casino St. Albert, Century Mile Racetrack in Edmonton and Casino Century Downs Racetrack and Casino in Calgary, and Poland; Casinos Poland.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.